Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
American Journal of Physiology. Endocrinology and Metabolism
|
May 29, 2000
Regulation of MAP kinase pathway activity in vivo in human skeletal muscle
A A Osman, M Pendergrass, J Koval, et al.
Diabetes Care
|
April 24, 2001
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone
Y Miyazaki, A Mahankali, M Matsuda, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 6, 2018
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme
K Cusi, N Sattar, L-E García-Pérez, et al.
Diabetologia
|
January 17, 2002
Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients
Y Miyazaki, L Glass, C Triplitt, et al.
Clinical Pharmacology and Therapeutics
|
March 16, 2007
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus
R Berria, L Glass, A Mahankali, et al.
Diabetes
|
October 27, 2001
Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation
W Pratipanawatr, T Pratipanawatr, K Cusi, et al.
The Journal of Clinical Investigation
|
February 17, 2000
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
K Cusi, K Maezono, A Osman, et al.
Diabetologia
|
April 24, 2004
Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes
A E Civitarese, C P Jenkinson, D Richardson, et al.
Diabetes, Obesity & Metabolism
|
October 11, 2016
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
K Cusi, A J Sanyal, S Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
American Journal of Physiology. Endocrinology and Metabolism
|
May 29, 2000
Regulation of MAP kinase pathway activity in vivo in human skeletal muscle
A A Osman, M Pendergrass, J Koval, et al.
Diabetes Care
|
April 24, 2001
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone
Y Miyazaki, A Mahankali, M Matsuda, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 6, 2018
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme
K Cusi, N Sattar, L-E García-Pérez, et al.
Diabetologia
|
January 17, 2002
Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients
Y Miyazaki, L Glass, C Triplitt, et al.
Clinical Pharmacology and Therapeutics
|
March 16, 2007
Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus
R Berria, L Glass, A Mahankali, et al.
Diabetes
|
October 27, 2001
Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation
W Pratipanawatr, T Pratipanawatr, K Cusi, et al.
The Journal of Clinical Investigation
|
February 17, 2000
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
K Cusi, K Maezono, A Osman, et al.
Diabetologia
|
April 24, 2004
Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes
A E Civitarese, C P Jenkinson, D Richardson, et al.
Diabetes, Obesity & Metabolism
|
October 11, 2016
Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
K Cusi, A J Sanyal, S Zhang, et al.
Page
of 2